合理设计一种抗疟疾,具有增强的蛋白质溶解稳定性和保存的寄生虫入侵抑制活性
Abhisek Kar1, Akash Narayan1, Vishal Malik1
1Tata Institute of Fundamental Research Hyderabad 36/p Gopanpally Hyderabad Telangana - 500046 India kmandal@tifrh.res.in.
RSC chemical biology
|November 22, 2024
概括
使用d-氨基酸和共价接的工程酸显示出对蛋白酶的增强稳定性. 这些修改后的保持了目标亲和力,并显示出基于的治疗方法的前景.
科学领域:
- 生物化学和药物化学 医学化学
- 体工程是什么? 体工程是什么?
- 药物发现 药物发现 药物发现
背景情况:
- 化学可以易受蛋白质分解的降解,限制它们的治疗潜力.
- 修改结构对于提高稳定性和有效性至关重要.
- 向Plasmodium falciparum侵入红细胞 (RBC) 是疟疾治疗的一个关键策略.
研究的目的:
- 为了增强对Plasmodium falciparum的化学抑制剂的蛋白质溶解稳定性.
- 研究d-氨基酸结合和共价交叉链接对的稳定性和活性的影响.
- 为治疗应用开发具有改善药理动力学特性的新型类型.
主要方法:
- 合理的化学工程策略,包括d-氨基酸替代和二硫化键的形成.
- 设计和合成异体性化学 (RR-I,RR-II) 和一个循环模拟物 (RR-III).
- 在体外评估蛋白质溶解稳定性,酶降解耐受性和抑制P. falciparum入侵的抑制活性.
主要成果:
- 工程化RR-I和RR-II显著增强了蛋白质溶解稳定性,同时保持了抑制活性.
- 循环模拟RR-III表现出与RR-II相比较的抑制活性,具有较强的抗酶降解能力.
- 在人体血中,RR-III表现出长时间的稳定性,表明药物动力学概况有所改善.
结论:
- 加入d-氨基酸和共价修改有效地提高了的蛋白质溶解稳定性.
- 量身定制的基因工程可以产生强效和稳定的抑制剂用于治疗.
- 开发的体显示出作为下一代治疗方法的希望,特别是在疟疾等传染病中.
更多相关视频
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
11.8K
12:02An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
12.0K
相关概念视频
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...